113 related articles for article (PubMed ID: 6484432)
1. Importance of mazindol in the treatment of narcolepsy.
Vespignani H; Barroche G; Escaillas JP; Weber M
Sleep; 1984; 7(3):274-5. PubMed ID: 6484432
[No Abstract] [Full Text] [Related]
2. Mazindol in the treatment of narcolepsy.
Parkes JD; Schachter M
Acta Neurol Scand; 1979 Oct; 60(4):250-4. PubMed ID: 525256
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effects of mazindol on narcolepsy.
Iijima S; Sugita Y; Teshima Y; Hishikawa Y
Sleep; 1986; 9(1 Pt 2):265-8. PubMed ID: 3704452
[TBL] [Abstract][Full Text] [Related]
4. Amphetamine, mazindol, and fencamfamin in narcolepsy.
Shindler J; Schachter M; Brincat S; Parkes JD
Br Med J (Clin Res Ed); 1985 Apr; 290(6476):1167-70. PubMed ID: 2859077
[TBL] [Abstract][Full Text] [Related]
5. [Value of mazindol in Gélineau's disease. Apropos of 10 cases].
Vespignani H; Weber M; Atlas P; Barroche G
Rev Electroencephalogr Neurophysiol Clin; 1986 Oct; 16(3):317-22. PubMed ID: 3809694
[TBL] [Abstract][Full Text] [Related]
6. Mazindol in long-term treatment of narcolepsy.
Alvarez B; Dahlitz M; Grimshaw J; Parkes JD
Lancet; 1991 May; 337(8752):1293-4. PubMed ID: 1674093
[No Abstract] [Full Text] [Related]
7. [Advances in the psychopharmacological management of the narcoleptic patient].
Salín-Pascual RJ; de la Fuente JR
Acta Psiquiatr Psicol Am Lat; 1985 Mar; 31(1):62-8. PubMed ID: 4050495
[TBL] [Abstract][Full Text] [Related]
8. Mazindol in narcolepsy and idiopathic and symptomatic hypersomnia refractory to stimulants: a long-term chart review.
Nittur N; Konofal E; Dauvilliers Y; Franco P; Leu-Semenescu S; Cock VC; Inocente CO; Bayard S; Scholtz S; Lecendreux M; Arnulf I
Sleep Med; 2013 Jan; 14(1):30-6. PubMed ID: 23036267
[TBL] [Abstract][Full Text] [Related]
9. AN 448 Sandoz (Mazindol) in the treatment of obesity.
Wallace AG
Med J Aust; 1976 Mar; 1(11):343-5. PubMed ID: 775265
[TBL] [Abstract][Full Text] [Related]
10. [Mazindol: a new anorectic drug].
Siani V
Clin Ter; 1978 Jan; 84(1):100-1. PubMed ID: 630811
[No Abstract] [Full Text] [Related]
11. [Mazindol in the treatment of simple obesity].
Siciński A; Stasiakowa L
Pol Arch Med Wewn; 1976 Jun; 55(6):581-7. PubMed ID: 781631
[No Abstract] [Full Text] [Related]
12. Mazindol.
Med Lett Drugs Ther; 1982 Oct; 24(621):98. PubMed ID: 7144688
[No Abstract] [Full Text] [Related]
13. The effect of mazindol on growth hormone secretion in boys with Duchenne muscular dystrophy.
Coakley JH; Moorcraft J; Hipkin LJ; Smith CS; Griffiths RD; Edwards RH
J Neurol Neurosurg Psychiatry; 1988 Dec; 51(12):1551-7. PubMed ID: 3221222
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of obesity with mazindol (author's transl)].
Escher M
Schweiz Rundsch Med Prax; 1976 Jun; 65(24):751-4. PubMed ID: 981189
[No Abstract] [Full Text] [Related]
15. Treatment of cocaine abuse with mazindol.
Berger P; Gawin F; Kosten TR
Lancet; 1989 Feb; 1(8632):283. PubMed ID: 2563451
[No Abstract] [Full Text] [Related]
16. [Mazindol in the treatment of obese diabetic patients].
Dolecek R; Reil P; Skarpová O; Závada M
Vnitr Lek; 1976 Aug; 22(8):798-804. PubMed ID: 788327
[No Abstract] [Full Text] [Related]
17. [Clinical use of mazindol in the treatment of essential obesity].
Guazzelli R; Piazzini M; Conti C; Papi L; Strazzulla G; Matassi L
Clin Ter; 1987 Mar; 120(5):385-91. PubMed ID: 2953538
[No Abstract] [Full Text] [Related]
18. [Use of mazindol in the dietetic treatment of obesity in patients with essential hypertension].
Kocemba J; Kawecka-Jaszcz K
Pol Arch Med Wewn; 1978 Dec; 60(6):517-23. PubMed ID: 366579
[No Abstract] [Full Text] [Related]
19. [Mazindol in the treatment of obesity in diabetics (author's transl)].
Felt V; Nedvídková J
Cas Lek Cesk; 1977 Sep; 116(39):1214-7. PubMed ID: 922789
[No Abstract] [Full Text] [Related]
20. [Mazindol (AN 448 Sandoz) in ambulatory treatment of obesity; its effect on body composition and adipose tissue].
Rath R; Vondra K; Wenkeová J
Cesk Gastroenterol Vyz; 1977 Sep; 31(6):389-94. PubMed ID: 589677
[No Abstract] [Full Text] [Related]
[Next] [New Search]
